Andrea Henden

1.3k total citations
24 papers, 540 citations indexed

About

Andrea Henden is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Andrea Henden has authored 24 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in Andrea Henden's work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (6 papers). Andrea Henden is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (6 papers). Andrea Henden collaborates with scholars based in Australia, United States and Germany. Andrea Henden's co-authors include Geoffrey R. Hill, Adam G. Stewart, Motoko Koyama, Antiopi Varelias, Rachel D. Kuns, Andrew D. Clouston, Ping Zhang, Bruce R. Blazar, Renee J. Robb and Mariapia A. Degli‐Esposti and has published in prestigious journals such as Blood, Immunity and The Journal of Immunology.

In The Last Decade

Andrea Henden

19 papers receiving 537 citations

Peers

Countries citing papers authored by Andrea Henden

Since Specialization

Citations

This map shows the geographic impact of Andrea Henden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Henden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Henden more than expected).

Fields of papers citing papers by Andrea Henden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Henden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Henden. The network helps show where Andrea Henden may publish in the future.

Co-authorship network of co-authors of Andrea Henden

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Henden. A scholar is included among the top collaborators of Andrea Henden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Henden. Andrea Henden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome 2025 ·Blood Advances ·(unknown), Glen Kennedy, Merrilyn Banks, Bernadine M. Flanagan, Andrea Henden	0
2	Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation 2025 ·Expert Review of Anti-infective Therapy ·(unknown), Krispin Hajkowicz, (unknown), Andrea Henden	0
3	p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice 2025 ·Pathology ·(unknown), Michael R. Tallack, (unknown), (unknown), Hnin Hnin Aung, Andrea Henden, Lee Jones, (unknown)	0
4	Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells 2024 ·Cytotherapy ·(unknown), (unknown), Ping Zhang, (unknown), Mei Tan, Alda Saldan, Andrea Henden, Cheryl Hutchins, (unknown), (unknown), (unknown), (unknown), Glen Kennedy, Geoffrey R. Hill, Siok‐Keen Tey	2
5	Exploratory Cost-Utility Analysis of a 37-Gene Panel Versus Usual Care to Guide Therapy for Patients with Intermediate-Risk Myeloid Malignancies 2024 ·Applied Health Economics and Health Policy ·Daniel Lindsay, Andrea Henden, (unknown), Thomas M. Elliott, (unknown)	0
6	Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years 2023 ·Clinical and Experimental Medicine ·Anna Maria Peri, Felicity Edwards, Andrea Henden, Patrick N. A. Harris, Mark D. Chatfield, David L. Paterson, Kevin B. Laupland	7
7	PET assessment of acute gastrointestinal graft versus host disease 2023 ·Bone Marrow Transplantation ·(unknown), Andrea Henden, Glen Kennedy, Siok‐Keen Tey	4
8	Fibre intake and supplementation during treatment for haematological malignancies: A scoping review 2023 ·Journal of Human Nutrition and Dietetics ·(unknown), Andrea Henden, Heidi M. Staudacher, Glen Kennedy, Nicole Gavin	3
9	ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease 2023 ·Internal Medicine Journal ·Nada Hamad, Ian Bilmon, (unknown), Andrea Henden, Anna Johnston, Duncan Purtill, Ashish Bajel, Siok‐Keen Tey, David T Yeung, Theresa Cole, (unknown), Jason Butler	0
10	Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program 2022 ·Blood ·(unknown), (unknown), (unknown), Cameron Curley, Siok‐Keen Tey, Jason Butler, Andrea Henden, (unknown), Cheryl Hutchins, (unknown), Glen Kennedy	1
11	A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis 2021 ·Blood ·Glen Kennedy, Siok‐Keen Tey, Luke Buizen, Antiopi Varelias, Kate H. Gartlan, Cameron Curley, Stuart D. Olver, (unknown), Jason Butler, Ashish Misra, (unknown), A. James Morton, Simon Durrant, Andrea Henden, John J. Moore, David Ritchie, David Gottlieb, Julian Cooney, Sanjoy K. Paul, Geoffrey R. Hill	32
12	Diverse IL-6 signalling modalities drive pathogenic T cell differentiation and graft-versus-host-disease after allotransplantation 2020 ·The Journal of Immunology ·Kate H. Gartlan, A Wilkinson, (unknown), Rachel D. Kuns, Andrea Henden, Simone A. Minnie, Kathleen S. Ensbey, Andrew D. Clouston, Ping Zhang, Motoko Koyama, Juan Hidalgo, Stefan Rose‐John, Antiopi Varelias, Slavica Vučković, Geoffrey R. Hill	1
13	Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract 2019 ·Blood Advances ·Kate H. Gartlan, Motoko Koyama, Katie E. Lineburg, (unknown), Kathleen S. Ensbey, Rachel D. Kuns, Andrea Henden, Luke Samson, Andrew D. Clouston, Angel F. López, Kelli P. A. MacDonald, Geoffrey R. Hill	19
14	IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling 2019 ·Blood ·A Wilkinson, (unknown), Rachel D. Kuns, Andrea Henden, Simone A. Minnie, Kathleen S. Ensbey, Andrew D. Clouston, Ping Zhang, Motoko Koyama, Juan Hidalgo, Stefan Rose‐John, Antiopi Varelias, Slavica Vučković, Kate H. Gartlan, Geoffrey R. Hill	32
15	Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation 2019 ·Blood Advances ·Andrea Henden, Antiopi Varelias, (unknown), (unknown), Judy Avery, (unknown), Stuart D. Olver, Luke Samson, Günter Härtel, Simon Durrant, Jason Butler, (unknown), Ashish Misra, Siok‐Keen Tey, (unknown), Cameron Curley, Glen Kennedy, Geoffrey R. Hill	14
16	MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota 2019 ·Immunity ·Motoko Koyama, Pamela Mukhopadhyay, Iona S. Schuster, Andrea Henden, Jan Hülsdünker, Antiopi Varelias, Marie Vétizou, Rachel D. Kuns, Renee J. Robb, Ping Zhang, Bruce R. Blazar, Ranjeny Thomas, Jakob Begun, Nicola Waddell, Giorgio Trinchieri, Robert Zeiser, Andrew D. Clouston, Mariapia A. Degli‐Esposti, Geoffrey R. Hill	159
17	Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD 2018 ·Clinical Cancer Research ·Kate A. Markey, Rachel D. Kuns, (unknown), Kate H. Gartlan, Renee J. Robb, José Paulo Martins, Andrea Henden, Simone A. Minnie, Melody Cheong, Motoko Koyama, Mark J. Smyth, Raymond J. Steptoe, Gabrielle T. Belz, Thomas Brocker, Mariapia A. Degli‐Esposti, Steven Lane, Geoffrey R. Hill	14
18	Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome 2017 ·Blood ·Antiopi Varelias, Kate L. Ormerod, Mark D. Bunting, Motoko Koyama, Kate H. Gartlan, Rachel D. Kuns, Nancy Lachner, Kelly R. Locke, (unknown), Andrea Henden, Ping Zhang, Andrew D. Clouston, Sumaira Z. Hasnain, Michael A. McGuckin, Bruce R. Blazar, Kelli P. A. MacDonald, Philip Hugenholtz, Geoffrey R. Hill	52
19	Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. 2017 ·The Journal of Immunology ·Antiopi Varelias, Kate L. Ormerod, Mark D. Bunting, Motoko Koyama, Kate H. Gartlan, Rachel D. Kuns, Nancy Lachner, Kelly R. Locke, (unknown), Andrea Henden, Ping Zhang, Andrew D. Clouston, Sumaira Z. Hasnain, Michael A. McGuckin, Bruce R. Blazar, Kelli P. A. MacDonald, Philip Hugenholtz, Geoffrey R. Hill	1
20	Myeloid and lymphoid neoplasm with FGFR1 abnormality 2008 ·British Journal of Haematology ·Colm Keane, Andrea Henden, Anthony K. Mills, Peter Wood	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact